Octadecadienylcarnitine
|
Basic information |
| Metabolite name | Octadecadienylcarnitine |
 | HMDB0006469 |
 |
N/A |
 |
6450015 |
| Synonyms | Decadienylcarnitine; |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | Octadecadienylcarnitine |
| HMDB0006469 |
|
N/A |
|
6450015 |
| Synonyms | Decadienylcarnitine; |
| No. of studies | 5 |
|
Relationship between Octadecadienylcarnitine and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1021 | Type1 | depression group vs. control group | Plasma | Human | Up |
| Study M1021 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M741 | Type2 | MDD group, post vs. before SSRI treatment | Plasma | Human | Down |
| Study M779 | Type4 | responder group vs. non-responder group, at baseline | Plasma | Human | Down |
| Study M823 | Type2 | CUMS + albiflorin group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M947 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M947 | Type2 | CUMS + high dose of Chaigui granules group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M947 | Type2 | CUMS + middle dose of Chaigui granules group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |